Related Experiment Video
Updated: Mar 3, 2026

06:40
Biofunctionalization of Magnetic Nanomaterials
Published on: July 16, 2020
3.1K
Next-generation superparamagnetic iron oxide nanoparticles for cancer theranostics
Kai Li1, Hossein Nejadnik1, Heike E Daldrup-Link1
1Department of Radiology and Molecular Imaging Program at Stanford (MIPS), Stanford School of Medicine, Stanford, CA, USA.
Drug Discovery Today
|April 30, 2017
Summary
New polymer-coated superparamagnetic iron oxide (SPIO) nanoparticles offer combined diagnostic and therapeutic capabilities for cancer treatment. These theranostic SPIO nanoparticles show promise for image-guided therapies.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Oncology
Background:
- Superparamagnetic iron oxide (SPIO) nanoparticles are crucial for MRI contrast agents.
- First-generation SPIO nanoparticles were limited to diagnostics.
- Next-generation SPIO nanoparticles possess multifunctional theranostic capabilities.
Purpose of the Study:
- To review recent advancements in polymer-coated multifunctional SPIO nanoparticles for cancer theranostics.
- To discuss the potential of these nanoparticles in image-guided cancer therapies.
- To explore current challenges and future directions in the field.
Main Methods:
- Literature review of recent studies on polymer-coated SPIO nanoparticles.
- Analysis of multifunctional characteristics for combined therapeutic and diagnostic applications.
- Evaluation of biocompatibility, biodegradability, and functional versatility.
Main Results:
- Polymer-coated theranostic SPIO nanoparticles exhibit enhanced biocompatibility and biodegradability.
- These nanoparticles offer versatile functionality for integrated cancer treatment.
- Recent developments focus on optimizing these nanoparticles for image-guided therapies.
Conclusions:
- Polymer-coated theranostic SPIO nanoparticles represent a significant advancement in cancer theranostics.
- They hold great potential for image-guided cancer therapies.
- Further research is needed to address current challenges and realize their full clinical potential.

